Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Artiva Biotherapeutics (ARTV) EBITDA Margin (2023 - 2024)

Historic EBITDA Margin for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q1 2024 value amounting to 5603.19%.

  • Artiva Biotherapeutics' EBITDA Margin changed N/A to 5603.19% in Q1 2024 from the same period last year, while for Dec 2024 it was 26219.12%, marking a year-over-year change of. This contributed to the annual value of 26219.12% for FY2024, which is 261342900.0% down from last year.
  • Per Artiva Biotherapeutics' latest filing, its EBITDA Margin stood at 5603.19% for Q1 2024.
  • Artiva Biotherapeutics' EBITDA Margin's 5-year high stood at 42.85% during Q3 2023, with a 5-year trough of 5603.19% in Q1 2024.